Neuralink’s First Human Patient: What We Know
In January 2024, Elon Musk’s neurotechnology company, Neuralink, achieved a significant milestone by implanting its brain-computer interface (BCI) into a human subject for the first time. The device, dubbed “Telepathy,” promises to bridge the gap between biological intelligence and digital platforms. For observers tracking this technology, the focus has shifted from theoretical presentations to real-world results. We now have concrete data regarding how the implant functions, who received it, and the specific mechanical challenges the team faced shortly after surgery.
Who is Noland Arbaugh?
The first human recipient of the Neuralink implant is Noland Arbaugh, a 29-year-old Arizona resident. Eight years prior to the surgery, Arbaugh suffered a freak diving accident that dislocated his C4 and C5 vertebrae. This injury resulted in quadriplegia, leaving him paralyzed from the shoulders down with no sensation or movement in his hands or legs.
Before the implant, Arbaugh relied on a mouth stick (a stylus held in the mouth) to interact with tablet computers. This method had limitations. It required a caregiver to set him up in an upright position, and prolonged use could lead to muscle fatigue or pressure sores. The Neuralink trial offered a potential alternative: direct control of a computer cursor through thought alone.
Inside the "Telepathy" N1 Implant
To understand the results, you must understand the hardware. The specific device implanted in Arbaugh is the N1. It is roughly the size of a large coin or a quarter. The device replaces a small circular section of the skull and sits flush with the bone, making it invisible under the skin once the incision heals.
The critical technology involves 64 flexible, ultra-thin polymer threads that extend from the device into the brain tissue. These threads contain a total of 1,024 electrodes. A surgical robot, specifically built by Neuralink for this task, inserted these threads into the motor cortex region of Arbaugh’s brain. This specific area controls hand and arm intentions.
The device works by detecting “action potentials,” or spikes in neural activity, that occur when Arbaugh intends to move his hand. The N1 records these signals and transmits them wirelessly to an app running on a nearby computer, which translates the neural patterns into cursor movements.
Capabilities: Gaming and Independence
The immediate results following the surgery were notable for their speed and accuracy. Arbaugh described the learning process as intuitive. He initially practiced by attempting to move his paralyzed hand, but he eventually learned to simply imagine the cursor moving.
Within weeks of the surgery, Arbaugh demonstrated several specific capabilities:
- Civilization VI: Arbaugh is an avid gamer. He reported playing the strategy game Civilization VI for eight hours straight. Before the implant, he required a friend to assist him physically with the mouse for such complex games.
- Mario Kart: In a video demonstration, Arbaugh played Mario Kart against his father and won. The latency (the delay between thought and action) was low enough to handle the fast-paced reaction times required for racing games.
- Online Chess: He demonstrated the ability to multitask, pausing music streams to play chess on a digital board with high precision.
The most significant metric for the industry is bits-per-second (BPS), which measures how fast and accurately a user can control the cursor. Neuralink engineers reported that Arbaugh achieved cursor control speeds that eclipsed previous records set by other BCI trials.
The Hardware Malfunction: Retracting Threads
Despite the initial success, the trial faced a mechanical setback roughly one month after surgery. The data rate from the N1 device began to drop significantly. Neuralink engineers discovered that a number of the 64 threads had retracted (pulled back) from the brain tissue.
Because the threads were no longer in the optimal position to record neural spikes, the device received fewer signals. This made cursor control sluggish and less accurate.
Why did this happen?
The human brain is not stationary; it pulses with each heartbeat and moves slightly within the skull during head movements. The Neuralink threads are free-floating and flexible. In animal trials, the brain-to-skull ratio is different, and the brain moves less. In a human skull, the space allows for more movement (micromotion), which likely contributed to the threads working their way out of the tissue.
The Software Fix
Rather than performing a risky surgery to remove or replace the implant, Neuralink addressed the issue through software updates. The engineering team modified the recording algorithm.
Originally, the system relied on specific, strong neural spikes. The update made the system more sensitive to neural population activity (averaged signals from groups of neurons) rather than just single-neuron spikes. This allowed the device to decode Arbaugh’s movement intentions accurately even with fewer active electrodes. According to Neuralink, this update not only restored Arbaugh’s performance but allowed him to surpass his initial BPS scores.
Competitors and Context
While Neuralink captures the most headlines, they are not the only player in this space. It is helpful to view their progress in context with other FDA-approved trials.
- Synchron: This company beat Neuralink to human trials in the US. Their device, the Stentrode, is inserted through the jugular vein and sits inside a blood vessel near the brain. This approach requires no open brain surgery. However, because it does not penetrate the brain tissue, the signal quality is generally lower (lower bandwidth) compared to Neuralink’s direct connection.
- Blackrock Neurotech: This company has implanted devices in dozens of patients over the last two decades. Their Utah Array is the “gold standard” for research but relies on a wired connection through the scalp (a port on the head), whereas Neuralink is fully wireless and cosmetic.
What Comes Next?
The current trial, known as the PRIME Study (Precise Robotically Implanted Brain-Computer Interface), is primarily focused on safety. The FDA approval allows Neuralink to implant the device in a limited number of participants to monitor for adverse effects like infection, stroke, or device failure.
Elon Musk has stated that future iterations of the device will target different conditions. A project casually named “Blindsight” aims to stimulate the visual cortex to restore sight to the blind. Another goal is to bridge the connection between the brain and the spinal cord, potentially allowing paralyzed patients to move their physical limbs again, rather than just a digital cursor.
For now, Noland Arbaugh continues to use the device daily. His experience provides the first roadmap for how consumer-grade brain chips might function in the real world, proving that while the hardware is fragile, the software may be flexible enough to compensate.
Frequently Asked Questions
Is the Neuralink implant permanent? The N1 is designed to be durable, but technology evolves rapidly. Neuralink claims the device is designed to be upgradeable, meaning it can be surgically removed and replaced with a newer model. However, removing threads that have integrated with brain tissue carries surgical risks that are still being evaluated.
Does the surgery hurt? The brain itself has no pain receptors. The surgery requires general anesthesia, but the patient does not feel the device once it is implanted. Noland Arbaugh reported a relatively easy recovery, returning home the day after the surgery.
Can the device be hacked? Cybersecurity is a major concern for any wireless device. The N1 transmits data via Bluetooth Low Energy to a nearby customized app. While no successful hacks have been reported, security researchers argue that any wireless medical device carries a theoretical risk of interference or data interception.
How much does the Neuralink implant cost? Currently, the device is not for sale. It is only available to participants in the FDA-approved clinical trials. Estimates for the eventual commercial cost vary wildly, but early projections suggest the surgery and device could cost around $40,000 to $50,000 once mass production begins, though this is speculative.